Creo Medical develops advanced medical technology and endoscopic healthcare solutions for clinicians and healthcare providers worldwide. Its mission is to improve patient outcomes by expanding the use of therapeutic endoscopy and supporting pathways that can reduce reliance on surgical intervention. The company’s products serve specialties including gastroenterology, urology, pulmonology and surgery, with solutions for procedures such as resection, ablation, diagnosis and treatment.

Creo’s Advanced Energy devices are powered by Kamaptive Technology, which combines high-frequency microwave and advanced bipolar radiofrequency energy. This technology enables miniature, minimally invasive endoscopic instruments designed to cut, coagulate and ablate tissue with precision and control. The product range includes devices such as Speedboat and Speedboat UltraSlim, alongside supporting endoscopy products and hygiene solutions.

Beyond its devices, Creo works with healthcare providers to support clinical adoption and improve patient pathways. Its services and resources include professional education and training through the Pioneer Programme, clinical publications, webinars, case studies, patient stories and a clinical resources hub.